Oral Presentation Guidelines

 

All presentations must be in English.

Session Structure

Please be present at least 30 minutes prior to the start time.

Sessions will be chaired by four jurors for each of the four sections.

Each author will have a time limit of maximum 7 minutes, followed by 3 minutes of discussions. Time limits will be strictly enforced. If the time limit is exceeded, there will be points deducted by the jury, as a penalty.

 

Presentation display

Pay attention to the legibility of the text on your slides and to the effective illustration of the information you present:

  • Do not overfill your slides with text;
  • Try to keep the use of words to a minimum: insert brief general ideas rather than full sentences;
  • Illustrate your points by using images, figures, schemes, charts, tables, graphs;
  • Choose a simple font and an appropriate size (20-30) for the text.

Scientific content

The structure of each presentation is most conveniently conceived by the author; however, we provide here some general suggestions for your presentation:

  • Organize your speech into paragraphs: Introduction/Background, Materials and methods, Results/Findings, Conclusion/Summary, Discussions, Future prospective, Acknowledgements, Bibliographic references;
  • Make sure you indicate the source of information whenever there is literature cited throughout the presentation text;
  • Give clear and concise information on the methods applied and interpretation of data;
  • Describe the originality and significance to the field of interest of your scientific approach.


 

ORAL PRESENTATION - EVALUATION CRITERIA

 

 

 

0

1

2

3

4

5

CRITERIA

Not present

Poor

Below average

Average

Good

Excellent

 

 

 

CRITERIA

SCORE

COMMENT

SCIENTIFIC CONTENT

Background information (pertinent literature cited)

 

 

Clear and concise materials and methods

 

 

Results

 

 

Discussion (interpretation of results)

 

 

Significance to field

 

 

Study design and approach to problem

 

 

The student was actively involved in designing and conducting the study

 

 

Logical order, minimum redundancy

 

 

The study presents an original concept

 

 

PRESENTATION

Smooth transitions

 

 

Legible (large fonts, good colour contrasts, minimum of words)

 

 

Proofed (no grammatical or spelling errors)

 

 

Effective use of figures and tables

 

 

Makes eye contact with audience

 

 

Effective use of time

 

 

 

TOTAL

 

 

 

 

 Example abstract: 

 

XRCC1 ARG194TRP POLYMORPHISM IS SIGNIFICANTLY ASSOCIATED WITH LUNG CANCER RISK IN ROMANIAN POPULATION


AUTHORS: SALOMEA-RUTH  HALMAGYI 
COORDINATORS: ASSISTANT PROFESSOR MARIUS FARCAS MD, PhD

INTRODUCTION: DNA repair play an important role in maintaining the integrity of the genome by repairing DNA damage induced by carcinogens. Certain genetic polymorphisms that occur in DNA repair genes may affect the ability to repair DNA defects and may represent a risk factor in carciogenesis. X-ray cross-complementing gene 1 (XRCC1), is involved in DNA repair. The purpose of our study was to investigate the association between XRCC1 Arg194Trp and Arg399Gln polymorphisms and the risk of lung cancer, in a Romanian population.


MATERIAL AND METHODS: We conducted a cross-sectional, randomized, case control study evaluating the frequency of XRCC1 Arg194Trp and Arg399Gln polymorphisms in female patients diagnosed with Lung cancer. A total of 102 patients diagnosed with lung cancer recruited from the Leon Daniello Pneumology Clinic, Cluj Napoca and 222 healthy controls were included in the study. Genotyping was carried
out using Multiplex PCR, followed by gel specific enzymatic digestion of the amplicons and gel electrophoresis for the resulting DNA fragments.


RESULTS: Statistical analysis (OR, recessive model), revealed an increased risk for lung cancer, for homozygous 194Trp genotype (χ2 = 0.186, p = 0.007, OR = 10.667 CI = 1.309 - 86,933). In conclusion, the results of the study place the XRCC1 Arg194Trp polymorphism among independent risk factors for developing lung cancer.


CONCLUSION: In conclusion, the results of the study place the XRCC1 Arg194Trp polymorphism among independent risk factors for developing lung cancer.

 

KEYWORDS: lung cancer, XRCC1 Arg194Trp, XRCC1 Arg399Gln polymorphism